Log in
RegisterReference trademark issue [Regulatives / Guidelines]
Dear All,
I prepared protocol for Mesalamine delayed-release tablets 1.2 gm for USFDA submission, i written reference name as Lialda™ (mesalamine) delayed release tablets 1.2 gm with trademark TM and the protocol was approved by EC. But as per COA it is mentioned as Lialda®, there is change in trademark. kindly suggest whether i need to go with ammendment/not.
Regards'
Kakarla
I prepared protocol for Mesalamine delayed-release tablets 1.2 gm for USFDA submission, i written reference name as Lialda™ (mesalamine) delayed release tablets 1.2 gm with trademark TM and the protocol was approved by EC. But as per COA it is mentioned as Lialda®, there is change in trademark. kindly suggest whether i need to go with ammendment/not.
Regards'
Kakarla
Complete thread:
- Reference trademark issuerajasekharkakarla 2018-07-24 09:05 [Regulatives / Guidelines]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Note to File Helmut 2018-07-24 16:57
- Note to File rajasekharkakarla 2018-07-30 13:37
- Note to File Helmut 2018-07-24 16:57
Ing. Helmut Schütz